Evaluation of the Decision-making During Multidisciplinary Meetings for Digestive Cancers
Prospective Evaluation of the Decision-making During Multidisciplinary Meetings for Digestive Cancers
1 other identifier
observational
200
1 country
1
Brief Summary
Nowadays, the recommended approach for decision-making for oncology patients is based on multidisciplinary meetings (MDT). However, the quality of decision-making during MDT depends on other factors such as the quality of presentation of clinical cases, the degree of participation of different specialists. In this study, the investigators will evaluate the decision-making during digestive oncology MDT using the validated "Metric Of Decision-Making" tool (MDT-MODe), in the national institute of oncology (Rabat, Morocco).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 23, 2019
CompletedFirst Submitted
Initial submission to the registry
June 22, 2019
CompletedFirst Posted
Study publicly available on registry
June 27, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 4, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2019
CompletedOctober 17, 2019
October 1, 2019
1 month
June 22, 2019
October 15, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
MODE-MDT scores
The scores of the Metric Of Decision-Making tool during multidisciplinary team meeting for digestive cancer. The instrument include 10 questions rated from 1 to 5. Higher scores indicate better results. The instrument include questions about the quality of clinical information (History, radiological, pathological, comorbid health conditions, psychosocial issues, and patients' views) and the contribution to team decision making of key professional groups (Surgeons, physicians, oncologists, nurses, allied healthcare professionals, radiologists, pathologists and MDT coordinators) ans a question about the decision (Clear, deferred, no decision. Each question is analyzed separately (mean, median, standard deviation, quartiles).
60 days from the multidisciplinary team meeting
Secondary Outcomes (2)
Decision reached
60 days from the multidisciplinary team meeting
Decision factors
60 days from the multidisciplinary team meeting
Interventions
No intervention. Observational study
Eligibility Criteria
Observations were carried out at digestive oncology multidisciplinary meetings at The National Institute of Oncology in Rabat, Morocco. The meetings are held once a week. The study will be performed between the 23rd of May and the 4th of July 2019.
You may qualify if:
- All consecutive cases presented during multidisciplinary cancer meeting for digestive cancer.
You may not qualify if:
- Cases not registered in the electronic health record system.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institut of oncology
Rabat, 10100, Morocco
MeSH Terms
Conditions
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 22, 2019
First Posted
June 27, 2019
Study Start
May 23, 2019
Primary Completion
July 4, 2019
Study Completion
September 1, 2019
Last Updated
October 17, 2019
Record last verified: 2019-10
Data Sharing
- IPD Sharing
- Will not share